Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × sacituzumab govitecan × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Solid Tumors 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

Bevacizumab 101 Fluorouracil 88 Leucovorin 86 Oxaliplatin 85 Irinotecan 76 Capecitabine 65 Cetuximab 54 Panitumumab 35 pembrolizumab 33 regorafenib 25 Nivolumab 22 Folfox protocol 19 IFL protocol 17 trifluridine tipiracil drug combination 11 durvalumab 11 Radiotherapy 11 Gemcitabine 8 tremelimumab 7 aflibercept 7 Cyclophosphamide 7 Celecoxib 7 binimetinib 6 Sunitinib 6 Drug Therapy 6 Colonoscopy 6 130-nm albumin-bound paclitaxel 6 cediranib 5 Trifluridine 5 Surgical Procedures, Operative 5 Immunoglobulin G 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡